1. Advances and perspectives in the management of varicella-zoster virus infections;Andrei;Molecules,2021
2. The varicella-zoster virus genome;Cohen;Curr. Top. Microbiol. Immunol.,2010
3. β-L-1-[5-(E-2-Bromovinyl)-2-(hydroxymethyl)-1,3-dioxolan-4-yl)] uracil (L-BHDU) effectiveness against varicella-zoster virus and herpes simplex virus type 1 depends on thymidine kinase activity;De;bioRxiv,2020
4. beta-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism;De;Antivir. Res.,2014
5. Antiviral drugs in current clinical use;De Clercq;J. Clin. Virol.,2004